Market Tracker

05/24 5:16pm ET

Ironwood Pharmaceuticals Inc (NASDAQ:IRWD)

12.06
Delayed Data
As of 4:00pm ET
 +0.62 / +5.42%
Today’s Change
7.35
Today|||52-Week Range
14.28
+4.06%
Year-to-Date
Why Synergy Pharmaceuticals Is Spiking 13% Today
May 16 / MotleyFool.com - Paid Partner Content
AstraZeneca slips on downgrade worries
Apr 26 / FT.com - Paid Partner Content
3 Risky Biotechs With FDA Decisions On Deck -- Are They Buys?
May 12 / MotleyFool.com - Paid Partner Content
 

Today’s Trading

Previous close11.44
Today’s open11.52
Day’s range11.47 - 12.08
Volume1,238,912
Average volume (3 months)1,635,921
Market cap$1.7B
Dividend yield--
Data as of 4:00pm ET, 05/24/2016

Growth & Valuation

Earnings growth (last year)+28.06%
Earnings growth (this year)+39.04%
Earnings growth (next 5 years)+39.00%
Revenue growth (last year)+95.66%
P/E ratioNM
Price/Sales11.02
Price/Book17.23

Competitors

 Today’s
change
Today’s
% change
CXRXConcordia Healthcare...-1.38-4.24%
EBSEmergent BioSolution...+0.44+1.05%
TXMDTherapeuticsMD Inc+0.03+0.35%
ITCIIntra-Cellular Thera...+0.17+0.46%
Data as of 4:02pm ET, 05/24/2016

Financials

Next reporting dateJuly 12, 2016
EPS forecast (this quarter)-$0.16
Annual revenue (last year)$149.6M
Annual profit (last year)-$142.7M
Net profit margin-95.40%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
Chief Executive Officer &
Director
Peter M. Hecht
Chief Financial Officer &
SVP-Corporate Strategy
Thomas Graney
Corporate headquarters
Cambridge, Massachusetts

Forecasts